Westmore · UDRP DecisionMyhr-cvs-login.com
The Panel ordered transfer of <myhr-cvs-login.com> to CVS Pharmacy, Inc. It found the domain confusingly similar to the CVS mark because it incorporated CVS in its entirety and the additional terms “my,” “hr,” and “login,” together with hyphens, did not avoid confusing similarity. The Respondent lacked authorization or other rights or legitimate interests, and the domain’s use for random websites, including a purported security check that redirected users toward a browser extension, supported findings of no legitimate interest and bad-faith registration and use.
The timeline behind myhr-cvs-login.com
Registration, the decision and the archived record of what this domain actually displayed — from public RDAP and the Internet Archive.
Westmore reconstructs the full history behind myhr-cvs-login.com — from public RDAP and the Internet Archive — as part of UDRP Intelligence:
This decision illustrates how a trademark combined with employee-access terminology can remain confusingly similar and can reinforce an apparent connection with the trademark owner. The outcome also shows the significance of evidence that a login-themed domain was used for misleading redirects rather than for any bona fide offering.
Result of record. The panel's reasoning and decisive facts behind each element are in the Intelligence dossier below.
WIPO Arbitration and Mediation Center ADMINISTRATIVE PANEL DECISION CVS Pharmacy, Inc. v. Registration Private, Domains By Proxy, LLC / Carolina Rodrigues, Fundacion Comercio Electronico Case No. D2019-1741 1. The Parties The Complainant is CVS Pharmacy, Inc., (hereinafter called “CVS”), United States of America (“United States” or “USA”), represented by The GigaLaw Firm, Douglas M. Isenberg, Attorney at Law, LLC, United States. The Respondent is Registration Private, Domains By Proxy, LLC, United States / Carolina Rodrigues, Fundacion Comercio Electronico, Panama. 2. The Domain Name and Registrar The disputed domain name <myhr-cvs-login.com> is registered with GoDaddy.com, LLC (the “Registrar”). 3. Procedural History The Complaint was filed with the WIPO Arbitration and Mediation Center (the “Center”) on July 22, 2019. On July 23, 2019, the Center transmitted by email to the Registrar a request for registrar verification in connection with the disputed domain name. On July 24, 2019, the Registrar transmitted by email to the Center its verification response disclosing registrant and contact information for the disputed domain name which differed from the named Respondent and contact information in the Complaint. The Center sent an email communication to the Complainant on July 25, 2019 providing the registrant and contact information disclosed by the Registrar and inviting the Complainant to submit an amendment to the Complaint. The Complainant filed an amendment to the Complaint on July 26, 2019. The Center verified that the Complaint together with the amendment to the Complaint satisfied the formal requirements of the Uniform Domain Name Dispute Resolution Policy (the “Policy” or “UDRP”), the Rules for Uniform Domain Name Dispute Resolution Policy (the “Rules”), and the WIPO Supplemental Rules for Uniform Domain Name Dispute Resolution Policy (the “Supplemental Rules”). In accordance with the Rules, paragraphs 2 and 4, the Center formally notified the Respondent of the Complaint, and the proceedings commenced on July 29, 2019. In accordance with the Rules, paragraph 5, the due date for Response was August 18, 2019. The Respondent did not submit any response. Accordingly, the Center notified the Respondent’s default on August 22, 2019. The Center appointed Clive Duncan Thorne as the sole panelist in this matter on August 28, 2019. The Panel finds that it was properly constituted. The Panel has submitted the Statement of Acceptance and Declaration of Impartiality and Independence, as required by the Center to ensure compliance with the Rules, paragraph 7. 4. Factual Background According to the Complainant, CVS, as can be seen from Annex 4 to the Complaint, is the principal operating company of CVS Health Corporation (“CVS Health”), a publicly traded corporation with in 2018 annual revenue of USD 194.6 billion. A copy of its 2018 annual report is exhibited as Annex 5. CVS is a direct, wholly owned subsidiary of CVS Health and holds many assets directly, including most of the relevant intellectual property interests, including the trade mark CVS and domain names containing the mark CVS. For the purposes of this decision, CVS and CVS Health are referred to interchangeably as the Complainant. The Complainant is the premier health innovation company in the USA, with more than 9,900 retail locations, approximately 1,100 walk-in clinics, a leading benefits manager with approximately 94 million members, a dedicated senior pharmacy care business serving more than 1 million patients per year, an expanding specialty pharmacy services and a leading stand-alone Medicare Part D prescription drug plan. The Complainant also serves an estimated 38 million customers through traditional, voluntary and consumer-directed health insurance products and related services, including rapidly expanding Medicare Advantage offerings. More detailed information about the Complainant is available on its websites at “www.cvs.com” and “www.cvshealth.com”. The Complainant is the registrant of and uses the domain names <cvs.com> (created January 30, 1996) and <cvshealth.com> (created April 15, 2005). Copies of the relevant WhoIs printouts are set out at Annex 7. The Complainant is the owner of at least 520 trade mark registrations worldwide consisting of or containing “CVS”. A schedule of these is attached at Annex 10. These include US registrations No. 919,941 registered on September 7, 1971, No. 1,698,636 registered on July 7, 1992, and No. 1,904,058 registered on July 11, 1995, all for the mark CVS. Print-outs from the USPTO database are set out at Annex 11. The Complainant expressly refers to a number of previous UDRP panel decisions which have found that the Complainant has rights in and to the CVS trade mark. The Complainant exhibits at Annex 1 a printout of the disputed domain name showing that it was registered by the Respondent on December 17, 2018. The Complainant also exhibits at Annex 8 evidence that the Respondent is using the disputed domain name in connection with a variety of random websites, including a website that falsely purports to offer a “Security Check“ but instead redirects users to another website where they are encouraged to install a Google Chrome extension called “Safe Net by Safely“, a similar variation of which (as can be seen from Annex 9) has been described as a “browser hijacker”. In the absence of a Response and evidence to the contrary, the Panel finds the evidence adduced by the Complainant to be true and proceeds to determine the Complainant on that basis. 5. Parties’ Contentions A. Complainant The Complainant submits: i. The disputed domain name is confusingly similar to the trade mark CVS in which the Complainant has rights. ii. The Respondent has no rights or legitimate interests in respect of the disputed domain name. The Respondent has not been granted rights by the Complainant. The Respondent has failed to show a bona fide offering of goods or services. The Respondent has never been commonly known by the disputed domain name. The use of the disputed domain name in connection with a variety of random websites is not a legitimate use. iii. The disputed domain name was registered and used in bad faith by the Respondent. The Respondent was aware of the Complainant’s trade mark rights when registering the disputed domain name. The Respondent’s use of the domain name in connection with a variety of random websites including the false offer of a “Security Check” is evidence of bad faith. B. Respondent The Respondent did not reply to the Complainant’s contentions. 6. Discussion and Findings A. Identical or Confusingly Similar As set out in section 4 above the Panel finds that the Complainant has registered trade mark rights in the mark CVS which pre-date registration of the disputed domain name. The disputed domain name <myhr-cvs-login.com> contains the mark CVS in its entirety. The domain name additionally consists of the word “my”, the letters “hr” and the word “login”. In respect of “my” the Complainant submits that this “additional word” is irrelevant and does nothing to alleviate confusing similarity. It relies upon earlier UDRP panel decisions including Delta Air Lines Inc. v. myself , WIPO Case No. D2013-0752 which have found that the addition of “my” to a complainant’s trade mark does nothing to diminish confusing similarity. It also relies upon TTS Tooltechnic Systems AG & Co. KG v . LAWRENCE RAY, THIS DOMAIN IS FOR SALE , WIPO Case No. D2019-0588 in which it was accepted that the term “my” is a common marketing supplement in ecommerce. This Panel follows these authorities and finds that the use of “my” is no more than a descriptive term which does not diminish the confusing similarity between the disputed domain name and the Complainant’s CVS mark. The Complainant submits that the use of the letters “hr” is an abbreviation for “human resources”. It relies upon earlier UDRP panel decisions to support this submission including Wim Bosman Holding B.V. v. Ipower, Inc ., WIPO Case No. D2014-0556 where it was held that the use of the prefix “hr” conveyed the idea that the domain name emanated from the complainant’s HR department. The Panel accepts this reasoning and finds that the use of “hr” within the disputed domain name refers to human resources and that the disputed domain name emanates from the CVS human resources department. The Complainant submits that the inclusion of the word “login” in the disputed domain name is irrelevant and does nothing to alleviate confusing similarity. It relies upon earlier UDRP panel decisions to support this view. For example, Discover Financial Services v. discover login, discover , WIPO Case No. D2018-2869 where a similar use of “login” was held not to prevent the disputed domain name from being considered confusingly similar. This Panel follows that reasoning and on the facts finds that the use of “login” is irrelevant in considering confusing similarity. The Complainant also submits that the two hyphens in the disputed domain name are irrelevant for the purposes of the Policy because the presence or absence of punctuation marks cannot on their own avoid a finding of confusing similarity. This is well established in earlier UDRP panel decisions including those cited by the Complainant, which this Panel follows, in finding that the two hyphens should not be taken into account in finding that the disputed domain name is confusingly similar to the mark CVS. The Panel therefore finds, in the absence of a Response, that the disputed domain name is confusingly similar to the trade mark CVS in which the Complainant has rights. B. Rights or Legitimate Interests The Panel accepts the Complainant’s evidence that it has never assigned, granted, licensed, sold, transferred or in any way authorized the Respondent to use the CVS trade mark. There is no evidence of any commercial relationship between the Complainant and the Respondent. The Complainant relies upon the evidence set out in Annex 8 that the Respondent is using the disputed domain name in connection with a variety of random websites, including a website that falsely purports to offer a “Security Check” but instead redirects users to another website where they are encouraged to install a Google Chrome extension called “Safe Net by Safely” a similar variation of which has been called a “browser hijacker”. It is well-established that the use of a domain name for illegal activity including “distributing malware, unauthorized account access / hacking” can never confer rights or legitimate interests upon a respondent. (see for example section 2.13 of WIPO Overview of WIPO Panel Views on Selected UDRP Questions , Third Edition (“WIPO Overview 3.0”). It follows, as submitted by the Complainant, that as a consequence the Respondent cannot show rights or legitimate interests within paragraph 4(c)(i) of the Policy. The Panel accepts this submission in the absence of contrary evidence. The Panel also finds on the evidence that the Respondent has never been commonly known by the disputed domain name and has not acquired rights in the domain name even though the “overall impression” of the disputed domain name is one of being connected to the trade mark of the Complainant. The Panel takes into account that the Complainant owns 520 trade mark registrations for CVS and which it has been using for 56 years, many years before registration of the disputed domain name in 2018. In the absence of a Response and contrary evidence, the Panel finds that the Respondent has no rights or legitimate interests in the disputed domain name within paragraph 4(a)(ii) of the Policy. C. Registered and Used in Bad Faith The Complainant submits that on the evidence the mark CVS is well known both in the USA and worldwide given that it is protected by at least 520 registrations worldwide. In particular, it relies upon previous UDRP panel decisions which have found that the mark is “famous and/or widely known”. The consequence of this is that the mere registration of a domain name identical or confusingly similar to a famous or widely-known trade mark can create a presumption of bad faith. Given the global reach and popularity of the Complainant’s services under the trade mark CVS as well as the similarity between the parties’ domain names and the use of the domain name means that it is “inconceivable that the Respondent chose to register the disputed domain name without knowledge of the Complainant’s activities and trade mark rights”. In the absence of evidence to the contrary the Panel accepts this submission. The Panel also takes into account the evidence, set out in Annex 8 to the Complaint, of the use of the disputed domain name in connection with the variety of random websites including the false offer of a “Security Check” but which redirects users to another website where they are encouraged to install the Google Chrome extension. The Panel agrees with the Complainant that such action constitutes bad faith because, inter alia , it disrupts the business of a competitor within paragraph 4(b)(iii) of the Policy and also “intentionally attempt to attract, for commercial gain, Internet users to the Respondent’s website […] by creating a likelihood of confusion with the complainant’s mark […]” within paragraph 4(b)(iv) of the Policy. The Panel therefore finds that the disputed domain name was registered and used in bad faith. 7. Decision For the foregoing reasons, in accordance with paragraphs 4(i) of the Policy and 15 of the Rules, the Panel orders that the disputed domain name <myhr-cvs-login.com> be transferred to the Complainant. Clive Duncan Thorne Sole Panelist Date: September 10, 2019
Source of record: WIPO . Reproduced for research; WIPO is the authoritative source.
What Westmore sees around myhr-cvs-login.com
The decision is only the record. Westmore connects it to the cases, authorities, panelists, parties and domain evidence surrounding it.
A short, grounded explanation drawn only from this decision's record — not legal advice or a prediction.
Grounded in the Westmore record for this decision. Research/informational only — not legal advice or a prediction of any outcome.
The decision is only the beginning.
You've seen what happened. Now discover the deeper intelligence behind the case, the panelist, the parties and the authorities that matter.
Go beyond the public record: see how this case has been cited, find comparable decisions, analyze the panelist and apply the relevant authorities to your Matter.
Westmore Professional · $395/month
Research with UDRP IntelligenceWestmore AI drafts an attorney-review-ready UDRP response from your facts, grounded in the exact panel and closest precedent.
$895 one-time per matter · no subscription required. Self-help drafting aid — not legal advice.
Build your responseWestmore UDRP records draw on WIPO-indexed decisions and are provided for research and informational purposes only. Not legal advice, a clearance opinion, or a prediction of any outcome.